FB2001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for FB2001, covering 2022-06-13 to 2023-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19 [Phase 2, Phase 3]